Astellas Pharma (Astellas Pharma) Price-to-Operating-Cash-Flow

: 11.07 (As of Today)

View and export this data going back to 2009. Start your Free Trial

As of today (2024-04-23), Astellas Pharma's share price is $9.50. Astellas Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.86. Hence, Astellas Pharma's Price-to-Operating-Cash-Flow Ratio for today is 11.07.

The historical rank and industry rank for Astellas Pharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

ALPMF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.99 Med: 12.98 Max: 56.47
Current: 12.11

During the past 13 years, Astellas Pharma's highest Price-to-Operating-Cash-Flow Ratio was 56.47. The lowest was 8.99. And the median was 12.98.

ALPMF's Price-to-Operating-Cash-Flow is ranked better than
63.02% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.1 vs ALPMF: 12.11

Astellas Pharma's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.20. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.86.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Astellas Pharma was -16.60% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 15.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 3.60% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 9.00% per year.

During the past 13 years, Astellas Pharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 65.60% per year. The lowest was -39.00% per year. And the median was 12.30% per year.

Astellas Pharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Astellas Pharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

12.40

14.13

10.31

13.74

10.48

Astellas Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															14.06	10.48	13.46	15.93	14.16

Competitive Comparison

For the Drug Manufacturers - General subindustry, Astellas Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astellas Pharma Price-to-Operating-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Astellas Pharma's Price-to-Operating-Cash-Flow falls into.

Astellas Pharma Price-to-Operating-Cash-Flow Calculation

Astellas Pharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	9.50	/	0.858
	=	11.07

Astellas Pharma's Share Price of today is $9.50.
Astellas Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.86.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Astellas Pharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Astellas Pharma (Astellas Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (OTCPK:ALPMF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

ALPMY:USA 4503:Mexico 4503:Japan YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.